These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17590270)

  • 41. Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase.
    Adler V; Bowne W; Michl J; Sookraj KA; Ikram K; Pestka S; Izotova L; Zenilman M; Friedman FK; Qu Y; Pincus MR
    Ann Clin Lab Sci; 2008; 38(1):47-56. PubMed ID: 18316782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression.
    Milsom C; Yu J; May L; Meehan B; Magnus N; Al-Nedawi K; Luyendyk J; Weitz J; Klement P; Broze G; Mackman N; Rak J
    Thromb Res; 2007; 120 Suppl 2():S82-91. PubMed ID: 18023719
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The tyrosine phosphatase Shp2 (PTPN11) in cancer.
    Chan G; Kalaitzidis D; Neel BG
    Cancer Metastasis Rev; 2008 Jun; 27(2):179-92. PubMed ID: 18286234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vav1 fine tunes p53 control of apoptosis versus proliferation in breast cancer.
    Sebban S; Farago M; Gashai D; Ilan L; Pikarsky E; Ben-Porath I; Katzav S
    PLoS One; 2013; 8(1):e54321. PubMed ID: 23342133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of knockout mice reveals a synergistic role of the Vav1 and Rasgrf2 gene deficiencies in lymphomagenesis and metastasis.
    Ruiz S; Santos E; Bustelo XR
    PLoS One; 2009 Dec; 4(12):e8229. PubMed ID: 20011522
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulating Vav1 phosphorylation by the SHP-1 tyrosine phosphatase is a fine-tuning mechanism for the negative regulation of DISC formation and Fas-mediated cell death signaling.
    Koncz G; Kerekes K; Chakrabandhu K; Hueber AO
    Cell Death Differ; 2008 Mar; 15(3):494-503. PubMed ID: 18064043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. VAV1: a new target in pancreatic cancer?
    Denicola G; Tuveson DA
    Cancer Biol Ther; 2005 May; 4(5):509-11. PubMed ID: 15970675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit?
    Felsher DW
    Cancer Res; 2008 May; 68(9):3081-6; discussion 3086. PubMed ID: 18451131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
    Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
    Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of hematopoietic stem cells by the steel factor/KIT signaling pathway.
    Kent D; Copley M; Benz C; Dykstra B; Bowie M; Eaves C
    Clin Cancer Res; 2008 Apr; 14(7):1926-30. PubMed ID: 18381929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. VAV1 mutations contribute to development of T-cell neoplasms in mice.
    Fukumoto K; Sakata-Yanagimoto M; Fujisawa M; Sakamoto T; Miyoshi H; Suehara Y; Nguyen TB; Suma S; Yanagimoto S; Shiraishi Y; Chiba K; Bouska A; Kataoka K; Ogawa S; Iqbal J; Ohshima K; Chiba S
    Blood; 2020 Dec; 136(26):3018-3032. PubMed ID: 32992343
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulatory interplay between Vav1, Syk and β-catenin occurs in lung cancer cells.
    Boudria R; Laurienté V; Oudar A; Harouna-Rachidi S; Dondi E; Le Roy C; Gardano L; Varin-Blank N; Guittat L
    Cell Signal; 2021 Oct; 86():110079. PubMed ID: 34252536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vav1 in hematologic neoplasms, a mini review.
    Oberley MJ; Wang DS; Yang DT
    Am J Blood Res; 2012; 2(1):1-8. PubMed ID: 22432082
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lysine Acetylation Reshapes the Downstream Signaling Landscape of Vav1 in Lymphocytes.
    Rodríguez-Fdez S; Fernández-Nevado L; Lorenzo-Martín LF; Bustelo XR
    Cells; 2020 Mar; 9(3):. PubMed ID: 32143292
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vav1 mutations identified in human cancers give rise to different oncogenic phenotypes.
    Shalom B; Farago M; Pikarsky E; Katzav S
    Oncogenesis; 2018 Oct; 7(10):80. PubMed ID: 30297765
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of the spectrum of trivalent VAV1-mutation-driven tumours using a gene-edited mouse model.
    Robles-Valero J; Fernández-Nevado L; Cuadrado M; Lorenzo-Martín LF; Fernández-Pisonero I; Abad A; Redín E; Montuenga L; Martín-Zanca D; Bigas A; Mallo M; Dosil M; Bustelo XR
    Mol Oncol; 2022 Oct; 16(19):3533-3553. PubMed ID: 35895495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process.
    Grassilli S; Brugnoli F; Lattanzio R; Rossi C; Perracchio L; Mottolese M; Marchisio M; Palomba M; Nika E; Natali PG; Piantelli M; Capitani S; Bertagnolo V
    Oncotarget; 2014 Jun; 5(12):4320-36. PubMed ID: 24962430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cancer-associated mutations in VAV1 trigger variegated signaling outputs and T-cell lymphomagenesis.
    Robles-Valero J; Fernández-Nevado L; Lorenzo-Martín LF; Cuadrado M; Fernández-Pisonero I; Rodríguez-Fdez S; Astorga-Simón EN; Abad A; Caloto R; Bustelo XR
    EMBO J; 2021 Nov; 40(22):e108125. PubMed ID: 34617326
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas.
    Abate F; da Silva-Almeida AC; Zairis S; Robles-Valero J; Couronne L; Khiabanian H; Quinn SA; Kim MY; Laginestra MA; Kim C; Fiore D; Bhagat G; Piris MA; Campo E; Lossos IS; Bernard OA; Inghirami G; Pileri S; Bustelo XR; Rabadan R; Ferrando AA; Palomero T
    Proc Natl Acad Sci U S A; 2017 Jan; 114(4):764-769. PubMed ID: 28062691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. VAV's got rhythm.
    Baylis HA
    Cell; 2005 Oct; 123(1):5-7. PubMed ID: 16213207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.